Recent advances in endoluminal revascularization for intracranial atherosclerotic disease

Neurological Research

Volumn 27, Issue SUPPL. 1, 2005, Pages

  Sauvageau, Eric ^a   Ecker, Robert D ^a   Levy, Elad I ^a   Hanel, Ricardo A ^a   Guterman, Lee R ^a   Hopkins, L Nelson ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Intracranial atherosclerosis; Stent; Treatment

Indexed keywords

ABCIXIMAB; ACETAZOLAMIDE; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; PROTAMINE; RAPAMYCIN; STAINLESS STEEL; TIROFIBAN; WARFARIN;

ANGIOPLASTY; BALLOON; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; DRUG HALF LIFE; ENDOVASCULAR SURGERY; HUMAN; INCIDENCE; NEUROIMAGING; PATIENT SELECTION; PROGNOSIS; RESTENOSIS; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STENT; STROKE; SURGEON; SYMPTOM; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE; TREATMENT INDICATION; UNITED STATES;

ENDARTERECTOMY; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; PATIENT SELECTION; STENTS;

EID: 27144534482     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X35486     Document Type: Review

References (61)

1. Ruygrok PN, Serruys PW. Intracoronary stenting. From concept to custom. Circulation 1996; 94: 882-890
2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495
3. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20
4. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27: 1974-1980
5. EC/IC Bypass Study Group: failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313: 1191-1200
6. Hopkins LN, Budny JL. Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 1989; 70: 207-211
7. Hopkins LN, Budny JL, Castellani D. Extracranial-intracranial arterial bypass and basilar artery ligation in the treatment of giant basilar artery aneurysms. Neurosurgery 1983; 13: 189-194
8. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490-497
9. North American Symptomatic Carotid Endarterectomy Trial Collaborators: beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453
10. Sundt TM, Jr, Smith HC, Campbell JK, et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980; 55: 673-680
11. Gomez CR, Misra VK, Campbell MS, et al. Elective stenting of symptomatic middle cerebral artery stenosis. Am J Neurol Res Am J Neuroradiol 2000; 21: 971-973
12. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000; 31: 95-99
13. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001; 48: 1215-1223
14. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004; 35: 1375-1380
15. Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol. 1999; 20: 787-789
16. Rasmussen PA, Perl J, 2nd, Barr JD, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 2000; 92: 771-778
17. Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: experience and complications. Am J Neurol Res Am J Neuroradiol 1997; 18: 1661-1668
18. Connors JJ, 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999; 91: 415-423
19. Mori T, Mori K, Fukuoka M, et al. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997; 39: 111-116
20. SSYLVIA Study Investigators: Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35: 1388-1392
21. Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002; 97: 1294-1301
22. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501
23. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533
24. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780
25. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231
26. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502
27. Chimowitz MI. WASID Trial. Neurosurgery Grand Rounds, Millard Fillmore Gates Circle Hospital (Buffalo NY), August 5, 2004
28. Yarab N. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study. American Stroke Association 28th International Conference. Available at: http://www.strokeconference.org/sc_includes/pdfs/CTP10.pdf (accessed December 6, 2004)
29. Bogousslavsky J, Barnett HJ, Fox AJ, et al. Atherosclerotic disease of the middle cerebral artery. Stroke 1986; 17: 1112-1120
30. Craig DR, Meguro K, Watridge C, et al. Intracranial internal carotid artery stenosis. Stroke 1982; 13: 825-828
31. Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: long-term prognosis. Stroke 1982; 13: 821-824
32. Moufarrij NA, Little JR, Furlan AJ, et al. Vertebral artery stenosis: long-term follow-up. Stroke 1984; 15: 260-263
33. Arenillas JF, Rovira A, Molina CA, et al. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002; 33: 2197-2203
34. Hoeffner EG, Case I, Jain R, et al. Cerebral perfusion CT: technique and clinical applications. Radiology 2004; 231: 632-644
35. Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002; 33: 2025-2031
36. Lanzino G, Fessler RD, Miletich RS, et al. Angioplasty and stenting of basilar artery stenosis: technical case report. Neurosurgery 1999; 45: 404-408
37. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. Am J Neurol Res Am J Neuroradiol 2001; 22: 928-936
38. Kittusamy PK, Koenigsberg RA, McCormick DJ. Abciximab for the treatment of acute distal embolization associated with internal carotid artery angioplasty. Catheter Cardiovasc Interv 2001; 54: 221-233
39. Tong FC, Cloft HJ, Joseph GJ, et al. Abciximab rescue in acute carotid stent thrombosis. Am J Neurol Res Am J Neuroradiol 2000; 21: 1750-1752
40. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002; 33: 1916-1919
41. Steinhubl SR, Berger PB, Mann JT, 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. J Am Med Ass 2002; 288: 2411-2420
42. Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. Am J Neurol Res Am J Neuroradiol 1998; 19: 1525-1533
43. Alazzaz A, Thornton J, Aletich VA, et al. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 2000; 57: 1625-1630
44. Callahan AS, 3rd, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimag 1997; 7: 232-235
45. Clark WM, Barnwell SL, Nesbit G, et al. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995; 26: 1200-1204
46. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993; 78: 192-198
47. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999; 30: 1065-1069
48. McKenzie JD, Wallace RC, Dean BL, et al. Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis. Am J Neurol Res Am J Neuroradiol 1996; 17: 263-268
49. Nahser HC, Henkes H, Weber W, et al. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. Am J Neurol Res Am J Neuroradiol 2000; 21: 1293-1301
50. Terada T, Higashida RT, Halbach VV, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiat 1996; 60: 377-381
51. Touho H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995; 82: 953-960
52. Lylyk P, Cohen JE, Ceratto R, et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. Am J Neurol Res Am J Neuroradiol 2002; 23: 430-436
53. Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. Am J Neurol Res Am J Neuroradiol 2000; 21: 249-254
54. Morris PP, Martin EM, Regan J, et al. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. Am J Neurol Res Am J Neuroradiol 1999; 20: 1688-1694
55. Nakahara T, Sakamoto S, Hamasaki O, et al. Stent-assisted angioplasty for intracranial atherosclerosis. Neuroradiology 2002; 44: 706-710
56. Ramee SR, Dawson R, McKinley KL, et al. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv 2001; 52: 457-467
57. Koning R, Eltchaninoff H, Commeau P, et al. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation 2001; 104: 1604-1608
58. Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004; 100: 688-694
59. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study with the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002; 106: 1949-1956
60. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794
61. Levy EI, Boulos AS, Hanel RA, et al. In vivo model of intracranial stent implantation: a pilot study to examine the histological response of cerebral vessels after randomized implantation of heparin-coated and uncoated endoluminal stents in a blinded fashion. J Neurosurg 2003; 98: 544-553